Ratings by CCB Int'l
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 10/9/2026 | N/A | Biogen | BIIB | New Coverage | Outperform (N/A) |
N/A (N/A) |
218.43 (243.10) |
11.29% | Details |
| 9/18/2026 | N/A | Neurocrine Bio. | NBIX | New Coverage | Outperform (N/A) |
N/A (N/A) |
151.83 (142.00) |
-6.47% | Details |
 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
| 19 more... | |||||||||
